Showing results (1-10 of 5,818) with videos related to
Sort By:
Pageof 582
Cancer Discovery|September 2, 2022
Why ARNT Prostate Tumors Responding to Enzalutamide?Meng Zhang, Thaidy Moreno-Rodriguez, David A QuigleyBiorxiv : the Preprint Server for Biology|June 19, 2024
A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapyAishwarya Subramanian, Meng Zhang, Marina Sharifi, et al.Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.NPJ Genomic Medicine|February 23, 2024
Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancerDebanjan Saha, Ha X Dang, Meng Zhang, et al.The Journal of Clinical Investigation|October 1, 2024
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancerXiaolin Zhu, Tatyanah Farsh, Daniël Vis, et al.Genome Biology|April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancerThaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.Molecular Oncology|November 27, 2015
Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cellsDavid A Quigley, Vessela KristensenBioinformatics (Oxford, England)|August 16, 2023
AARDVARK: an automated reversion detector for variants affecting resistance kineticsThaidy Moreno, Joaquin Magana, David A QuigleyCancer Research|June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate CancerArian Lundberg, Meng Zhang, Rahul Aggarwal, et al.Nature Genetics|July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancerShuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.Pageof 582